Learn how UV light intensity is measured, how distance and wavelength affect irradiance, and why measurement conditions matter for UV safety.

This article explains light intensity through irradiance, including its units, formula, distance relationship, measurement methods, thermal effects, and test conditions. It clarifies why electrical wattage and brightness claims cannot replace calibrated irradiance data when evaluating red light therapy devices.

Laser therapy can provide targeted benefits, but its drawbacks vary by procedure. Thermal injury, pigment changes, infection, recovery demands, trained-operator requirements, cost, and limited access may affect decisions. This article explains risk factors, regulatory distinctions, follow-up needs, and practical questions to discuss with a qualified clinician.

There is no universal waiting period for red light therapy after laser treatment. Timing depends on the laser type, wound status, device parameters, heat, and individual healing. Controlled clinical PBM differs from unsupervised home use, so clinician approval is essential, especially after ablative procedures.

This guide explains the five essential dosage metrics for at-home laser therapy for dogs: wavelength, irradiance, illuminated area, exposure time, and radiant exposure. It also compares laser and LED devices, reviews current evidence, and outlines practical safety and device-selection considerations.

Red light therapy may support selected outcomes, including hair density and knee osteoarthritis disability, but evidence varies widely by condition and protocol. This evidence-based review examines 13 potential benefits, possible risks, device evaluation, dosing variables, regulatory claims, and situations requiring professional medical guidance.

This evidence-based review examines whether red or near-infrared photobiomodulation can treat early COVID-19. Human trials remain preliminary, device-specific, and insufficient to prove viral clearance or broad clinical benefit. It explains proposed mechanisms, intranasal delivery, measurement standards, safety, regulatory limits, and why proven antiviral care should take priority.

Conventional red and near-infrared photobiomodulation does not reliably kill viruses or bacteria, disinfect surfaces, or treat infections. This article distinguishes PBM from germicidal UV-C and antimicrobial photodynamic inactivation, explains evidence limits, clarifies FDA terminology, and stresses that infection care requires validated medical and disinfection protocols.

This article explains that medication warnings for sunlight or UV exposure do not automatically prove an interaction with red or near-infrared light. It outlines higher-risk situations, device parameters, IEC 62471 limits, and why patients should consult a prescriber before combining medication with photobiomodulation.

This evidence review examines how photobiomodulation may influence macrophage signaling, inflammatory mediators, and polarization markers. It finds promising but highly parameter-dependent cell and animal evidence, limited direct human data, and no proof that red light therapy universally boosts immunity or prevents infection.

PBM research for lymphatic conditions focuses mainly on breast-cancer-related lymphedema. Evidence suggests possible adjunctive benefits, but protocols and certainty remain limited. The article explains mechanisms, dosing, safety risks, and device documentation while rejecting universal home-treatment or “lymphatic detox” claims.

This article examines how photobiomodulation may affect the lymphatic system and reviews the strongest human evidence for breast-cancer-related lymphedema. It explains biological mechanisms, clinical limits, device specifications, safety considerations, and why laser-trial results should not be generalized to consumer LED devices or wellness claims.